Pharmicell Co: Revenue and profit surged on Bio Chemical growth and AI material demand, with strong margins

About this update from Pharmicell Co., Ltd

Revenue and profits soared year-over-year, led by Bio Chemical segment growth and strong demand for AI and pharmaceutical materials. The company improved margins, expanded capacity, and maintained robust liquidity, while continuing to invest in R&D and manage financial risks.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Pharmicell Co., Ltd